ENTITY
Daiichi Sankyo

Daiichi Sankyo (4568 JP)

221
Analysis
Health Care β€’ Japan
Daiichi Sankyo Co, Ltd is a holding company established through merger of Sankyo and Daiichi pharmaceutical. The Group manufactures pharmaceuticals for human/veterinary use and medical tools and equipment. It also researches and promotes products through related companies throughout the world. The Group also produces food, food additives, livestock feeds, and agrochemicals.
more
β€’01 Mar 2021 06:19

πŸ‡―πŸ‡΅ JAPAN β€’ The Post-COVID Rotation Accelerates

Over the last 20 trading days during which TOPIX reached 1,974.99, many market leaders have seen a significant correction, and there has been a...

Logo
318 Views
Share
bullishβ€’Cross Asset Strategy
β€’24 Feb 2021 11:26

Global Fund Positioning in Japan:Β  Underweight and Underowned

With the Nikkei 225 index breaking 30k this month,Β  Global managers remain under-invested and underweight Japan versus the benchmark MSCI All...

Logo
388 Views
Share
β€’01 Feb 2021 06:47

πŸ‡―πŸ‡΅ JAPAN β€’ Market + Results & Revisions Update 01/29

Thursday's Vale Traded ratio was the highest year-to-date and the third-highest since the COVID-low of 13th March 2020. Down Volume reached 'Panic'...

Logo
286 Views
Share
x